Copper induces the expression of cholesterogenic genes in human macrophages

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 71-76

  Svensson, Per Arne ^a,b   Englund, Mikael C O ^b   Markström, Emilia ^c   Ohlsson, Bertil G ^b   Jernås, Margareta ^a   Billig, Håkan ^c   Torgerson, Jarl S ^c   Wiklund, Olov ^b   Carlsson, Lena M S ^a   Carlsson, Björn ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Atherosclerosis; Copper; DNA microarray; Lipid accumulation; Macrophages; Wilson's disease

Indexed keywords

CHOLESTEROL; COPPER; ENZYME; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; ISOPENTENYL DIPHOSPHATE DELTA ISOMERASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; METHYLSTEROL MONOOXYGENASE; SQUALENE MONOOXYGENASE; SQUALENE SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FATTY LIVER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; WILSON DISEASE;

EID: 0038645170     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00145-X     Document Type: Article

References (34)

1. Ford E.S. Serum copper concentration and coronary heart disease among US adults. Am. J. Epidemiol. 151:2000;1182-1188.
2. Salonen J.T., Salonen R., Korpela H., Suntioinen S., Tuomilehto J. Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland. Am. J. Epidemiol. 134:1991;268-276.
3. Kok F.J., Van Duijn C.M., Hofman A., et al. Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am. J. Epidemiol. 128:1988;352-359.
4. Klevay L.M., Inman L., Johnson L.K., et al. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism. 33:1984;1112-1118.
5. He J.A., Tell G.S., Tang Y.C., Mo P.S., He G.Q. Relation of serum zinc and copper to lipids and lipoproteins: the Yi People Study. J. Am. Coll. Nutr. 11:1992;74-78.
6. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963-20966.
7. Carew T.E., Schwenke D.C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84:1987;7725-7729.
8. Prasad K., Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am. Heart J. 125:1993;958-973.
9. Ferns G.A., Lamb D.J., Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis. 133:1997;139-152.
10. Volker W., Dorszewski A., Unruh V., Robenek H., Breithardt G., Buddecke E. Copper-induced inflammatory reactions of rat carotid arteries mimic restenosis/arteriosclerosis-like neointima formation. Atherosclerosis. 130:1997;29-36.
11. Ohlsson B.G., Englund M.C., Karlsson A.L., et al. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J. Clin. Invest. 98:1996;78-89.
12. Hultberg B., Andersson A., Isaksson A. The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress. Toxicology. 123:1997;33-40.
13. Benson M., Svensson P.A., Carlsson B., et al. DNA microarrays to study gene expression in allergic airways. Clin. Exp. Allergy. 32:2002;301-308.
14. Pucheu S., Coudray C., Tresallet N., Favier A., de Leiris J. Effect of dietary antioxidant trace element supply on cardiac tolerance to ischemia-reperfusion in the rat. J. Mol. Cell. Cardiol. 27:1995;2303-2314.
15. Lamb D.J., Reeves G.L., Taylor A., Ferns G.A. Dietary copper supplementation reduces atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis. 146:1999;33-43.
16. Hellman N.E., Gitlin J.D. Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22:2002;439-458.
17. Lamb D.J., Leake D.S. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein. FEBS Lett. 338:1994;122-126.
18. Ehrenwald E., Chisolm G.M., Fox P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93:1994;1493-1501.
19. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 107:2003;363-369.
20. Pang J.H., Chau L.Y. Copper-induced apoptosis and immediate early gene expression in macrophages. Atherosclerosis. 146:1999;45-52.
21. Licastro F., Morini M.C., Chiricolo M., et al. Plasmic levels of trace elements and immune functions in the healthy elderly. J. Trace Elem. Electrolytes Health Dis. 7:1993;234-236.
22. Dalessandri K.M., Eisele P., Wong T.S., Parker J., Rucker R.B. Elastin degradation in the aorta of Watanabe hereditary hyperlipidemic rabbits. Mech. Ageing Dev. 74:1994;117-120.
23. Osborne T.F. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275:2000;32379-32382.
24. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109:2002;1125-1131.
25. al-Othman A.A., Rosenstein F., Lei K.Y. Copper deficiency increases in vivo hepatic synthesis of fatty acids, triacylglycerols, and phospholipids in rats. Proc. Soc. Exp. Biol. Med. 204:1993;97-103.
26. Kim S., Chao P.Y., Allen K.G. Inhibition of elevated hepatic glutathione abolishes copper deficiency cholesterolemia. FASEB J. 6:1992;2467-2471.
27. Shao M.J., Lei K.Y. Conversion of [2-14C] mevalonate into cholesterol, lanosterol and squalene in copper-deficient rats. J. Nutr. 110:1980;859-867.
28. Tang Z., Gasperkova D., Xu J., Baillie R., Lee J.H., Clarke S.D. Copper deficiency induces hepatic fatty acid synthase gene transcription in rats by increasing the nuclear content of mature sterol regulatory element binding protein 1. J. Nutr. 130:2000;2915-2921.
29. Wilson J., Kim S., Allen K.G., Baillie R., Clarke S.D. Hepatic fatty acid synthase gene transcription is induced by a dietary copper deficiency. Am. J. Physiol. 272:1997;E1124-E1129.
30. Fields M., Lewis C.G. Hepatic iron overload may contribute to hypertriglyceridemia and hypercholesterolemia in copper-deficient rats. Metabolism. 46:1997;377-381.
31. Scheinberg I.H., Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am. J. Clin. Nutr. 63:1996;842S-845S.
32. Horton J.D., Shimomura I., Brown M.S., Hammer R.E., Goldstein J.L., Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 101:1998;2331-2339.
33. Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., Goldstein J.L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98:1996;1575-1584.
34. Horton J.D., Shimano H., Hamilton R.L., Brown M.S., Goldstein J.L. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. J. Clin. Invest. 103:1999;1067-1076.